{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:51:31Z","timestamp":1783529491238,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Instituto de Oncolog\u00eda \u201c\u00c1ngel H. Roffo\u201d"},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires\u201d; UBACYT","doi-asserted-by":"publisher","award":["20720150100001BA"],"award-info":[{"award-number":["20720150100001BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"CONICET PIP","doi-asserted-by":"publisher","award":["11220150100112CO"],"award-info":[{"award-number":["11220150100112CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"CONICET PIP","doi-asserted-by":"publisher","award":["9671\/14 2015\u20132017"],"award-info":[{"award-number":["9671\/14 2015\u20132017"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Escuela T\u00e9cnica ORT","award":["PICT 2016 0585"],"award-info":[{"award-number":["PICT 2016 0585"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.niox.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T02:22:23Z","timestamp":1583461343000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment"],"prefix":"10.1016","volume":"98","author":[{"given":"Yanina Ver\u00f3nica","family":"Langle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Patricia","family":"Balarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Belgorosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Dami\u00e1n","family":"Cresta Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Omar","family":"Sandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Rojas","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Lodillinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Eij\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2020.03.003_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.niox.2020.03.003_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2020.03.003_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","article-title":"Predicting response to intravesical Bacillus calmette-guerin immunotherapy: are we there yet? A systematic review","volume":"73","author":"Kamat","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.niox.2020.03.003_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.niox.2020.03.003_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.urolonc.2018.02.018","article-title":"Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy","volume":"36","author":"Ornstein","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.niox.2020.03.003_bib6","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1172\/JCI89717","article-title":"ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence","volume":"127","author":"Chevalier","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2020.03.003_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.niox.2005.04.012","article-title":"The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans","volume":"13","author":"Mitropoulos","year":"2005","journal-title":"Nitric Oxide : Biol. Chem."},{"key":"10.1016\/j.niox.2020.03.003_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.niox.2004.11.003","article-title":"Expression of inducible nitric oxide synthase in tumoral and non-tumoral epithelia from bladder cancer patients","volume":"12","author":"Sandes","year":"2005","journal-title":"Nitric Oxide : Biol. Chem."},{"key":"10.1016\/j.niox.2020.03.003_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.juro.2012.04.099","article-title":"Inducible nitric oxide synthase and PPARgamma are involved in bladder cancer progression","volume":"188","author":"Sandes","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2020.03.003_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.niox.2013.10.010","article-title":"Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS","volume":"36","author":"Belgorosky","year":"2014","journal-title":"Nitric Oxide : Biol. Chem."},{"key":"10.1016\/j.niox.2020.03.003_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013571","article-title":"Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model","volume":"5","author":"Lodillinsky","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2020.03.003_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.niox.2020.03.003_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.niox.2020.03.003_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2020.03.003_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13058-015-0527-x","article-title":"Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer","volume":"17","author":"Granados-Principal","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.niox.2020.03.003_bib16","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.niox.2020.03.003_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbadis.2017.12.022","article-title":"Sustained anti-inflammatory effects of TGF-beta1 on microglia\/macrophages","volume":"1864","author":"Islam","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.niox.2020.03.003_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/niox.1996.0105","article-title":"Control of nitric oxide production by transforming growth factor-beta1: mechanistic insights and potential relevance to human disease","volume":"1","author":"Vodovotz","year":"1997","journal-title":"Nitric Oxide : Biol. Chem."},{"key":"10.1016\/j.niox.2020.03.003_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.freeradbiomed.2019.02.008","article-title":"Crosstalk between TAp73 and TGF-beta in fibroblast regulates iNOS expression and Nrf2-dependent gene transcription","volume":"134","author":"Cabrie","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2020.03.003_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/medicina55060302","article-title":"Prognostic impact of canonical TGF-beta signaling in urothelial bladder cancer","volume":"55","author":"Stojnev","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.niox.2020.03.003_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10735-015-9633-4","article-title":"TGFbeta modulates inflammatory cytokines and growth factors to create premetastatic microenvironment and stimulate lung metastasis","volume":"46","author":"Ye","year":"2015","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.niox.2020.03.003_bib22","first-page":"801","article-title":"Calprotectin (S100A8\/S100A9): a key protein between inflammation and cancer","volume":"67","author":"Shabani","year":"2018","journal-title":"Inflamm. Res. Off. J. Eur.Histamine.Res. Soc."},{"key":"10.1016\/j.niox.2020.03.003_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1541-7786.MCR-10-0394","article-title":"S100A8\/A9 activate key genes and pathways in colon tumor progression","volume":"9","author":"Ichikawa","year":"2011","journal-title":"Mol. Canc. Res. : MCR"},{"key":"10.1016\/j.niox.2020.03.003_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","article-title":"S100A9 a new marker for monocytic human myeloid-derived suppressor cells","volume":"136","author":"Zhao","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.niox.2020.03.003_bib25","first-page":"64","article-title":"La expresi\u00f3n de S100A9 vinculada con el \u00f3xido n\u00edtrico, es un marcador de mal pron\u00f3stico en pacientes con c\u00e1ncer de vejiga, siendo su inhibici\u00f3n un posible blanco terap\u00e9utico","volume":"79","author":"Langle","year":"2014","journal-title":"Revista Argentina de Urolog\u00eda"},{"key":"10.1016\/j.niox.2020.03.003_bib26","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1096\/fj.15-273987","article-title":"Glycosylation-dependent interaction between CD69 and S100A8\/S100A9 complex is required for regulatory T-cell differentiation","volume":"29","author":"Lin","year":"2015","journal-title":"Faseb. J. : Off. Publ.Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.niox.2020.03.003_bib27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.niox.2020.03.003_bib28","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","article-title":"Shaping the immune landscape in cancer by galectin-driven regulatory pathways","volume":"428","author":"Rabinovich","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.niox.2020.03.003_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40425-015-0050-8","article-title":"Combination of IFNalpha and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction","volume":"3","author":"Muthuswamy","year":"2015","journal-title":"J.Immunother.Canc."},{"key":"10.1016\/j.niox.2020.03.003_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1016700","article-title":"Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells","volume":"4","author":"Wu","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.niox.2020.03.003_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-beta","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.niox.2020.03.003_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.niox.2020.03.003_bib33","first-page":"565","article-title":"Inhibition of bacillus Calmette-Guerin-induced nitric oxide in bladder tumor cells may improve BCG treatment","volume":"16","author":"Alvarez","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.niox.2020.03.003_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7150\/ijbs.4564","article-title":"Complexities of TGF-beta targeted cancer therapy","volume":"8","author":"Connolly","year":"2012","journal-title":"Int. J. Biol. Sci."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860320300045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860320300045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:05:33Z","timestamp":1761069933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860320300045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"alternative-id":["S1089860320300045"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2020.03.003","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}